These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25660136)

  • 1. Health care resource utilization and costs during episodes of care for type 2 diabetes mellitus-related comorbidities.
    Candrilli SD; Meyers JL; Boye K; Bae JP
    J Diabetes Complications; 2015; 29(4):529-33. PubMed ID: 25660136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
    Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
    Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiaries.
    Hazel-Fernandez L; Li Y; Nero D; Moretz C; Slabaugh L; Meah Y; Baltz J; Patel NC; Bouchard JR
    Am J Manag Care; 2015 Jan; 21(1):e62-70. PubMed ID: 25880269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease.
    Mehta S; Ghosh S; Sander S; Kuti E; Mountford WK
    J Manag Care Spec Pharm; 2018 Mar; 24(3):280-290. PubMed ID: 29485954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Changes in Medical Services and Related Costs in a Single Cohort of Patients Newly Diagnosed With Type 2 Diabetes, 2006 to 2012.
    Weng W; Liang Y; Kimball ES; Hobbs T; Kong S; Sakurada B; Bouchard J
    Clin Ther; 2016 Jun; 38(6):1314-1326. PubMed ID: 27129399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in prevalence of diabetic complications and associated healthcare costs during a 10-year follow-up period among a nationwide diabetic cohort.
    Chen HL; Hsu WW; Hsiao FY
    J Diabetes Complications; 2015; 29(4):523-8. PubMed ID: 25770886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database.
    Sato M; Ye W; Sugihara T; Isaka Y
    BMC Musculoskelet Disord; 2016 Nov; 17(1):489. PubMed ID: 27887655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular event costs in patients with Type 2 diabetes mellitus.
    Johnston SS; Sheehan JJ; Shah M; Cappell K; Princic N; Smith D; Kalsekar I
    J Med Econ; 2015; 18(12):1032-40. PubMed ID: 26189723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.
    Gandra SR; Lawrence LW; Parasuraman BM; Darin RM; Sherman JJ; Wall JL
    J Manag Care Pharm; 2006 Sep; 12(7):546-54. PubMed ID: 16981800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health care utilization and costs in type 2 diabetes mellitus and their association with renal impairment.
    Burke J; Kovacs B; Borton L; Sander S
    Postgrad Med; 2012 Mar; 124(2):77-91. PubMed ID: 22437218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare utilization of people with type 2 diabetes in Germany: an analysis based on health insurance data.
    Müller N; Heller T; Freitag MH; Gerste B; Haupt CM; Wolf G; Müller UA
    Diabet Med; 2015 Jul; 32(7):951-7. PubMed ID: 25781644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US.
    St Charles M; Minshall ME; Pandya BJ; Baran RW; Tunis SL
    Curr Med Res Opin; 2009 Jun; 25(6):1343-53. PubMed ID: 19419339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States.
    Foos V; Varol N; Curtis BH; Boye KS; Grant D; Palmer JL; McEwan P
    J Med Econ; 2015 Jun; 18(6):420-32. PubMed ID: 25629654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longitudinal study of healthcare utilisation and expenditure in people with type 2 diabetes mellitus with and without major depressive disorder.
    Huang CJ; Lin CH; Hsieh HM; Chang CC; Chu CC; Sun DP; Weng SF
    Gen Hosp Psychiatry; 2019; 57():50-58. PubMed ID: 30908962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-up.
    Chen HY; Kuo S; Su PF; Wu JS; Ou HT
    Diabetes Care; 2020 Aug; 43(8):1732-1740. PubMed ID: 32444454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system.
    Bahia LR; Araujo DV; Schaan BD; Dib SA; Negrato CA; Leão MP; Ramos AJ; Forti AC; Gomes MB; Foss MC; Monteiro RA; Sartorelli D; Franco LJ
    Value Health; 2011; 14(5 Suppl 1):S137-40. PubMed ID: 21839888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare Burden and Costs Associated with Urinary Tract Infections in Type 2 Diabetes Mellitus Patients: An Analysis Based on a Large Sample of 456,586 German Patients.
    Wilke T; Böttger B; Berg B; Groth A; Botteman M; Yu S; Fuchs A; Maywald U
    Nephron; 2016; 132(3):215-26. PubMed ID: 26930608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence and costs of hypoglycemia in type 2 diabetes.
    Quilliam BJ; Simeone JC; Ozbay AB; Kogut SJ
    Am J Manag Care; 2011 Oct; 17(10):673-80. PubMed ID: 22106460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of acute myocardial infarction and stroke on health care costs in patients with type 2 diabetes in Sweden.
    Ringborg A; Yin DD; Martinell M; Stålhammar J; Lindgren P
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):576-82. PubMed ID: 19491686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a chronic disease management service for patients with diabetes on hospitalisation and acute care costs.
    Rasekaba TM; Lim WK; Hutchinson AF
    Aust Health Rev; 2012 May; 36(2):205-12. PubMed ID: 22624643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.